The cardiovascular system is significantly affected in coronavirus disease-19 (COVID-19).
Microvascular injury, endothelial dysfunction, and thrombosis resulting from viral infection or …

Importance There has been limited research on patients with ST-segment elevation
myocardial infarction (STEMI) and COVID-19. Objective To compare characteristics …

Cardiovascular dysfunction and disease are common and frequently fatal complications of
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Indeed, from …

Aims The severity of myocardial tissue damage following ST-elevation myocardial infarction
(STEMI) strongly determines short-and long-term prognosis. This study explored the impact …

Early during the COVID-19 pandemic, it was recognized that infection with SARS-CoV-2 was
associated with an increased risk of both arterial and venous thrombotic complications. This …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for
coronavirus disease 2019 (COVID-19), has caused substantial mortality and morbidity …

Coronavirus disease 2019 is characterized by its severe respiratory effects. Data early on
indicated an increased risk of mortality in patients with cardiovascular comorbidities. Early …

Abstract Coronavirus disease 2019 (COVID-19) is caused by the novel severe acute
respiratory coronavirus-2 (SARS-CoV-2). Several explanations for the development of …

There is a paucity of data exploring the impact of gender, race, and insurance status on
invasive management and inhospital mortality in patients with COVID-19 with ST-elevation …

The onset and widespread dissemination of the severe acute respiratory syndrome
coronavirus-2 in late 2019 impacted the world in a way not seen since the 1918 H1N1 …